» Articles » PMID: 26193770

The Ubiquitin-proteasome System and Autophagy Are Defective in the Taurine-deficient Heart

Overview
Journal Amino Acids
Specialty Biochemistry
Date 2015 Jul 22
PMID 26193770
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Taurine depletion leads to impaired mitochondrial function, as characterized by reduced ATP production and elevated superoxide generation. These defects can fundamentally alter cardiomyocyte function and if left unchanged can result in cell death. To protect against these stresses, cardiomyocytes possess quality control processes, such as the ubiquitin-proteasome system (UPS) and autophagy, which can rejuvenate cells through the degradation of damaged proteins and organelles. Hence, the present study tested the hypothesis that reactive oxygen species generated by damaged mitochondria initiates UPS and autophagy in the taurine-deficient heart. Using transgenic mice lacking the taurine transporter (TauTKO) as a model of taurine deficiency, it was shown that the levels of ubiquitinated protein were elevated, an effect associated with a decrease in ATP-dependent 26S β5 proteasome activity. Treating the TauTKO mouse with the mitochondria-specific antioxidant, mitoTEMPO, largely abolished the increase in ubiquitinated protein content. The TauTKO heart was also associated with impaired autophagy, characterized by an increase in the initiator, Beclin-1, and autophagosome content, but a defect in the generation of active autophagolysosomes. Although mitoTEMPO treatment only restores the oxidative balance within the mitochondria, it appeared to completely disrupt the crosstalk between the damaged mitochondria and the quality control processes. Thus, mitochondrial oxidative stress is the main trigger initiating the quality control systems in the taurine-deficient heart. We conclude that the activation of the UPS and autophagy is another fundamental function of mitochondria.

Citing Articles

Taurine and Astrocytes: A Homeostatic and Neuroprotective Relationship.

Ramirez-Guerrero S, Guardo-Maya S, Medina-Rincon G, Orrego-Gonzalez E, Cabezas-Perez R, Gonzalez-Reyes R Front Mol Neurosci. 2022; 15:937789.

PMID: 35866158 PMC: 9294388. DOI: 10.3389/fnmol.2022.937789.


Cardioprotective effect of ginsenoside Rb1 via regulating metabolomics profiling and AMP-activated protein kinase-dependent mitophagy.

Hu J, Zhang L, Fu F, Lai Q, Zhang L, Liu T J Ginseng Res. 2022; 46(2):255-265.

PMID: 35509816 PMC: 9058834. DOI: 10.1016/j.jgr.2021.06.011.


Cytoprotective effect of taurine against sodium chlorate-induced oxidative damage in human red blood cells: an ex vivo study.

Ali S, Arif A, Ansari F, Mahmood R Amino Acids. 2022; 54(1):33-46.

PMID: 34993628 DOI: 10.1007/s00726-021-03121-5.


Taurine as a Natural Antioxidant: From Direct Antioxidant Effects to Protective Action in Various Toxicological Models.

Surai P, Earle-Payne K, Kidd M Antioxidants (Basel). 2021; 10(12).

PMID: 34942978 PMC: 8698923. DOI: 10.3390/antiox10121876.


Amino Acid and Phospholipid Metabolism as an Indicator of Inflammation and Subtle Cardiomyopathy in Patients with Marfan Syndrome.

Bartenbach L, Karall T, Koch J, Keller M, Oberacher H, Scholl-Burgi S Metabolites. 2021; 11(12).

PMID: 34940564 PMC: 8707072. DOI: 10.3390/metabo11120805.